Developer docs
API playgroundTry for free, no card

Search company profiles

Perflow Medical

Full company profile

uuid0003qwi

Namestring
Perflow Medical
Websiteurl
perflow.com
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Perflow Medical is an Israel-based, privately held medical device company founded in 2010 and headquartered in Netanya. Contextual notes indicate the company operates in the mechanical thrombectomy device segment, a neurovascular interventional category used in the treatment of acute ischemic stroke and related vascular occlusions, serving hospitals and interventional neuroradiology specialists. The firm maintains a lean operating footprint of 11-50 employees, with leadership comprising CEO Danny Farin, co-founder Avi Rapaport, a consulting CFO (Ido Nisenboim), a VP of R&D (Gilad Cibulski), and an Engineering Director (Eran Harari) — a structure indicating an R&D-led organization transitioning from development-stage toward commercialization.

The company's commercial and product details are not documented in the available source material: the corporate website (perflow.com) presents only a placeholder loading page, with no product catalog, technology description, regulatory clearances, patents, customer references, pricing, or distribution footprint disclosed. The only documented capital event is a $12,000,000 funding round completed on 2018-02-15, with both investors and lead investor unspecified. No subsequent funding events, acquisitions, partnerships, product launches, or geographic expansions are recorded in the input.

Given the thrombectomy device context, the company's likely business model follows the standard Israeli neurovascular medtech pattern: develop a differentiated catheter- or stent-retriever-based device, secure FDA 510(k) or CE Mark clearance, and sell through a combination of direct specialty sales and distributor agreements to hospital stroke centers and interventional neuroradiology departments. However, none of these go-to-market details are explicitly confirmed in the source data, and the absence of disclosed revenue, customers, and product specifications represents a significant information gap. The overall evidence base is thin, and any conclusions should be treated as preliminary.

Short descriptiontext

Perflow Medical is a privately held Israel-based medical device company founded in 2010 in Netanya, developing mechanical thrombectomy devices for the neurovascular interventional market serving hospital stroke centers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNetanya, Israel
HQ citystring
Netanya
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Keyword5 values
medical devices, mechanical thrombectomy, neurovascular devices, minimally invasive surgery, stroke intervention
Industry1 code
PRIMARYHLAFAIAO
Perioperative Supply Chain, Instruments & Surgical Logistics
Healthcare & Life Sciences/Healthcare Providers & Systems/Surgical Centers & Perioperative Care (ASCs)
NAICS code4 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
  • Medical Equipment and Supplies Manufacturing3391
  • Medical Equipment and Supplies Manufacturing33911
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Devices
Social media profiles1 record
Cost components5 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Perflow Medical is an Israel-based medical device company developing and commercializing medical devices, with available context referencing the mechanical thrombectomy device market. The company operates as a private for-profit medical device manufacturer with a small team of 11-50 employees, focused on interventional medical technology.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Mechanical thrombectomy devices
CategoryMedical Devices
Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Penumbra is a global leader in mechanical thrombectomy and neurovascular devices. It is comparable to Perflow Medical as a developer of catheter-based interventional devices used in ischemic stroke and peripheral vascular procedures, representing both a direct competitive threat and a likely strategic acquirer in the same category.

TypeDirect peer
Description

Rapid Medical is an Israel-based neurovascular device company developing minimally invasive tools for stroke treatment and other neurovascular interventions. It is highly comparable to Perflow as a same-geography, same-category, small-team competitor focused on catheter-based delivery platforms.

TypeDirect peer
Description

Route 92 Medical is a neurovascular company developing mechanical thrombectomy systems for acute ischemic stroke. It is comparable to Perflow as a focused, venture-backed peer developing catheter-based devices in the same endovascular therapeutic category.

TypeBroad incumbent
Description

Stryker's Neurovascular division (including the acquired Concentric Medical, Codman Neuro, and Surpass products) is a major incumbent in the mechanical thrombectomy and intracranial device market. It is comparable to Perflow as the dominant scaled buyer/competitor in the same endovascular device category.

TypeBroad incumbent
Description

Medtronic operates one of the broadest neurovascular and surgical instrument portfolios (including Solitaire and other thrombectomy/embolectomy devices). It is comparable to Perflow as a large incumbent competing in catheter-based neurovascular intervention and surgical instrumentation.

TypeBroad incumbent
Description

Cerenovus is J&J's neurovascular franchise, offering embolization, thrombectomy, and surgical instruments for stroke and vascular conditions. It is comparable to Perflow as a large incumbent with overlapping products in the same endovascular clinical workflow.

TypeEmerging player
Description

Vesalio is an emerging neurovascular company developing next-generation stent retriever and mechanical thrombectomy technologies. It is comparable to Perflow as a similarly-sized focused innovator competing in the same mechanical thrombectomy category.

TypeEmerging player
Description

Insera Therapeutics develops specialized devices for neurovascular and vascular procedures, including catheter-based treatment platforms. It is comparable to Perflow as a small, focused competitor in endovascular interventional devices.

9MicroPort Scientific
TypeBroad incumbent
Description

MicroPort is a diversified medical device company with significant neurovascular and surgical instrument product lines. It is comparable to Perflow as a broader incumbent with portfolio overlap in surgical and interventional medical devices.

TypeEmerging player
Description

Acandis is a German neurovascular specialist focused on implants and devices used in the treatment of stroke and intracranial aneurysms. It is comparable to Perflow as a focused, mid-sized developer of catheter-based neurovascular instruments.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Perflow Medical

Medical Devicesperflow.com

Perflow Medical is a privately held Israel-based medical device company founded in 2010 in Netanya, developing mechanical thrombectomy devices for the neurovascular interventional market serving hospital stroke centers.

What Perflow Medical does

Perflow Medical is an Israel-based, privately held medical device company founded in 2010 and headquartered in Netanya. Contextual notes indicate the company operates in the mechanical thrombectomy device segment, a neurovascular interventional category used in the treatment of acute ischemic stroke and related vascular occlusions, serving hospitals and interventional neuroradiology specialists. The firm maintains a lean operating footprint of 11-50 employees, with leadership comprising CEO Danny Farin, co-founder Avi Rapaport, a consulting CFO (Ido Nisenboim), a VP of R&D (Gilad Cibulski), and an Engineering Director (Eran Harari) — a structure indicating an R&D-led organization transitioning from development-stage toward commercialization.

The company's commercial and product details are not documented in the available source material: the corporate website (perflow.com) presents only a placeholder loading page, with no product catalog, technology description, regulatory clearances, patents, customer references, pricing, or distribution footprint disclosed. The only documented capital event is a $12,000,000 funding round completed on 2018-02-15, with both investors and lead investor unspecified. No subsequent funding events, acquisitions, partnerships, product launches, or geographic expansions are recorded in the input.

Given the thrombectomy device context, the company's likely business model follows the standard Israeli neurovascular medtech pattern: develop a differentiated catheter- or stent-retriever-based device, secure FDA 510(k) or CE Mark clearance, and sell through a combination of direct specialty sales and distributor agreements to hospital stroke centers and interventional neuroradiology departments. However, none of these go-to-market details are explicitly confirmed in the source data, and the absence of disclosed revenue, customers, and product specifications represents a significant information gap. The overall evidence base is thin, and any conclusions should be treated as preliminary.

Perflow Medical firmographics

Firmographics
Name
Perflow Medical
Website
https://perflow.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
11–50 employees
Short description
Perflow Medical is a privately held Israel-based medical device company founded in 2010 in Netanya, developing mechanical thrombectomy devices for the neurovascular interventional market serving hospital stroke centers.
Ownership category
akta.pro rank

Perflow Medical industry classification

Industry
Product category
Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391), Medical Equipment and Supplies Manufacturing (33911)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAFAIAO
Perioperative Supply Chain, Instruments & Surgical Logistics
Healthcare & Life Sciences/Healthcare Providers & Systems/Surgical Centers & Perioperative Care (ASCs)

Keywords

  • Medical devices
  • Mechanical thrombectomy
  • Neurovascular devices
  • Minimally invasive surgery
  • Stroke intervention

Where Perflow Medical is headquartered

Location

Headquarters

HQ city
Netanya
HQ country
Israel
HQ region
Middle East

Markets served

Perflow Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales

Perflow Medical product offering

Product offering

Core offering

Perflow Medical is an Israel-based medical device company developing and commercializing medical devices, with available context referencing the mechanical thrombectomy device market. The company operates as a private for-profit medical device manufacturer with a small team of 11-50 employees, focused on interventional medical technology.

Differentiator

Problem solved

Functional benefit

Products and services

  • Mechanical thrombectomy devices

Companies that use Perflow Medical

Customer profile

Ideal customer profiles1 record

Perflow Medical technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Perflow Medical partnerships and signals

Strategic signal

Recent moves2 records

Expansion highlights2 records

Perflow Medical competitors and assessment

Company assessment

Broad incumbents

  • Penumbra: Penumbra is a global leader in mechanical thrombectomy and neurovascular devices. It is comparable to Perflow Medical as a developer of catheter-based interventional devices used in ischemic stroke and peripheral vascular procedures, representing both a direct competitive threat and a likely strategic acquirer in the same category.
  • Stryker (Neurovascular): Stryker's Neurovascular division (including the acquired Concentric Medical, Codman Neuro, and Surpass products) is a major incumbent in the mechanical thrombectomy and intracranial device market. It is comparable to Perflow as the dominant scaled buyer/competitor in the same endovascular device category.
  • Medtronic: Medtronic operates one of the broadest neurovascular and surgical instrument portfolios (including Solitaire and other thrombectomy/embolectomy devices). It is comparable to Perflow as a large incumbent competing in catheter-based neurovascular intervention and surgical instrumentation.
  • Johnson & Johnson (Cerenovus): Cerenovus is J&J's neurovascular franchise, offering embolization, thrombectomy, and surgical instruments for stroke and vascular conditions. It is comparable to Perflow as a large incumbent with overlapping products in the same endovascular clinical workflow.
  • MicroPort Scientific: MicroPort is a diversified medical device company with significant neurovascular and surgical instrument product lines. It is comparable to Perflow as a broader incumbent with portfolio overlap in surgical and interventional medical devices.

Direct peers

  • Rapid Medical: Rapid Medical is an Israel-based neurovascular device company developing minimally invasive tools for stroke treatment and other neurovascular interventions. It is highly comparable to Perflow as a same-geography, same-category, small-team competitor focused on catheter-based delivery platforms.
  • Route 92 Medical: Route 92 Medical is a neurovascular company developing mechanical thrombectomy systems for acute ischemic stroke. It is comparable to Perflow as a focused, venture-backed peer developing catheter-based devices in the same endovascular therapeutic category.

Emerging players

  • Vesalio: Vesalio is an emerging neurovascular company developing next-generation stent retriever and mechanical thrombectomy technologies. It is comparable to Perflow as a similarly-sized focused innovator competing in the same mechanical thrombectomy category.
  • Insera Therapeutics: Insera Therapeutics develops specialized devices for neurovascular and vascular procedures, including catheter-based treatment platforms. It is comparable to Perflow as a small, focused competitor in endovascular interventional devices.
  • Acandis: Acandis is a German neurovascular specialist focused on implants and devices used in the treatment of stroke and intracranial aneurysms. It is comparable to Perflow as a focused, mid-sized developer of catheter-based neurovascular instruments.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

Perflow Medical social profiles

Digital presence

Perflow Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Perflow Medical leadership team

Management profile

Number of profiles

Profiles5 records

Perflow Medical funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Perflow Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Perflow Medical

What does Perflow Medical do?

Perflow Medical is an Israel-based medical device company developing and commercializing medical devices, with available context referencing the mechanical thrombectomy device market. The company operates as a private for-profit medical device manufacturer with a small team of 11-50 employees, focused on interventional medical technology.

Is Perflow Medical a public or private company?

Perflow Medical is a private company. It is classified as venture growth investor backed and is currently operating.

When was Perflow Medical founded?

Perflow Medical was founded in 2010. It employs 11 to 50 people.

Where is Perflow Medical based?

Perflow Medical is headquartered in Netanya, Israel, in the Middle East region.

Who are Perflow Medical's main competitors?

Broad incumbents on record are Penumbra, Stryker (Neurovascular), Medtronic, Johnson & Johnson (Cerenovus) and MicroPort Scientific. Direct peers are Rapid Medical and Route 92 Medical. Emerging players are Vesalio, Insera Therapeutics and Acandis.

Does Perflow Medical have an API?

No public API is recorded for Perflow Medical.

What industry is Perflow Medical in?

Perflow Medical's product category is Medical Devices. Its primary akta.pro industry code is HLAFAIAO, Perioperative Supply Chain, Instruments & Surgical Logistics. Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
IFTTTChinese fund buys Perflow Medical for $100mPerflow Medical, an Israeli neurovascular device company, was acquired by an unnamed Chinese private equity firm for about $100 million. The company, founded in 2014, develops devices for stroke treatment and has raised $17 million to date. Its first device received EU clearance in 2018 but has not yet received FDA approval.PR NewswirePerflow Medical erweitert Produktportfolio mit erstem klinischem Einsatze des Stream™17 Dynamic Neuro-ThrombektomienetzesPerflow Medical, an Israeli neurovascular treatment innovator, announced the first successful clinical use of its Stream™17 Dynamic Neuro-Thrombectomy Net device at Pauls Stradins Clinical University Hospital in Riga, Latvia, and Barts Health NHS Trust in London, UK. The low-profile device, compatible with 0.017-inch microcatheters, enables treatment of more distal blood vessels in patients with ischemic and hemorrhagic stroke using Perflow's proprietary CEREBRAL NET™ technology. The Stream17 and Cascade17 products are now commercially available in Europe for treating acute ischemic stroke and intracranial aneurysms respectively, though Perflow's devices are not yet approved for clinical use in the United States.PR NewswirePerflow Medical amplía su cartera de productos gracias a Stream™ 17Perflow Medical announced the successful first clinical use of its Stream™ 17 Dynamic Neuro-Thrombectomy Net device at Pauls Stradins Clinical University Hospital in Riga, Latvia, expanding its product portfolio for treating ischemic and hemorrhagic stroke patients. The lower-profile stentriever, built using the proprietary CEREBRAL NET™ technology, can navigate through smaller microcateters to reach previously inaccessible distal vessels and achieve complete recanalization. The Stream17 and Cascade17 products are now commercially available in Europe but have not yet received clinical approval for use in the United States.PR NewswirePerflow Medical Expands Product Portfolio with First Clinical Use of the Stream™17 Dynamic Neuro-Thrombectomy NetPerflow Medical, an Israeli-based medical device company, announced the first successful clinical use of its Stream™17 Dynamic Neuro-Thrombectomy Net for treating stroke patients, with the procedures performed at Pauls Stradins Clinical University Hospital in Riga, Latvia. The device utilizes Perflow's proprietary CEREBRAL NET™ technology and features a lower profile that enables navigation through smaller .017" microcatheters to reach previously unreachable blockages in more distal vessels. The Stream17 and Cascade Net product families are now commercially available across Europe, though Perflow products are not yet cleared for clinical use in the United States.PR NewswirePerflow Medical annonce la première utilisation clinique du filet remodelant dynamique non occlusif Cascade™ 17Perflow Medical, an Israeli neurovascular device company, has launched its Cascade™ 17 non-occlusive remodeling net in the European market, with the first clinical procedure performed by Dr. Xavier Barreau at CHU de Bordeaux in France. The device, based on Perflow's proprietary CEREBRAL NET™ technology platform, enables continuous blood flow during aneurysm repair and coil embolization in smaller, more distal intracranial vessels. Perflow Medical CEO Danny Farin stated this launch builds on the success of the Cascade product family and represents the first of several product announcements planned for 2021.PR NewswirePerflow Medical Announces the First Clinical Use of the Cascade™ 17 Dynamic Non-Occlusive Remodeling NetPerflow Medical announced the launch of its Cascade 17 Non-Occlusive Remodeling Net to the European market, with the first clinical procedure performed by Dr. Xavier Barreau at CHU de Bordeaux in France. The device enables continuous blood flow during cerebral aneurysm repair without requiring an occlusive balloon or stent. CEO Danny Farin indicated this is the first of several planned product announcements, including the upcoming Stream17 Dynamic Neuro-Thrombectomy Net.PR NewswirePerflow Medical anuncia el primer uso clínico de la red de remodelación no oclusiva dinámica Cascade™ 17Perflow Medical, an Israeli neurovascular device company headquartered in Netanya, announced the European market launch of its Cascade™ 17 non-occlusive remodeling net, designed for embolization of intracranial aneurysms in smaller vessels using its proprietary CEREBRAL NET™ braided platform technology. The first clinical use of the device was performed by Dr. Xavier Barreau at CHU de Bordeaux in France, who reported promising navigability and excellent coil support in challenging anatomical cases. The company noted this launch is the first of several upcoming product announcements, including the Stream17 neuro-thrombectomy net, while clarifying that Perflow products are not yet approved for clinical use in the United States.PR NewswirePerflow Medical recibe la aprobación de la marca CE por el nuevo Cascade™ AgilePerflow Medical, an Israeli privately held medical technology company, announced it has received CE mark approval for its Cascade Agile non-occlusive remodeling net, a device designed to treat intracranial aneurysms by improving control in distal and tortuous vessel anatomy during embolization procedures. The company also reported that a clinical article on its Cascade Net product was published in the Journal of NeuroInterventional Surgery, and said it plans to publish additional clinical experience with its Stream and Cascade Net products to support future commercial expansion within and outside Europe. Perflow is exhibiting its full neurovascular product family at the WFITN congress in Naples, Italy, this week, with the products currently commercially available across Europe, though not yet approved for clinical use in the United States.PR NewswirePerflow Medical obtient le marquage CE pour le nouveau Cascade™ AgilePerflow Medical, an Israeli medical technology company, has received CE marking approval for its Cascade™ Agile non-occlusive reshaping net designed for coil embolization treatment of intracranial aneurysms. The product expands Perflow's Cascade portfolio and offers enhanced control for physicians during procedures in tortuous distal vasculature. The company also announced clinical data on Cascade Net was published in the Journal of NeuroInterventional Surgery, with products now available in the European market but not yet approved for clinical use in the United States.PR NewswirePerflow Medical Receives CE Mark Approval of Novel Cascade™ AgilePerflow Medical, an Israeli-based neurovascular medical device company, has received CE Mark approval for its Cascade Agile Non-Occlusive Remodeling Net, expanding its product family for use during coil embolization of intracranial aneurysms. The device utilizes the company's proprietary CEREBRAL NET Technology platform and enables continuous blood flow during procedures without requiring vessel occlusion. The company plans to publish additional clinical data and expand commercially across Europe and other markets.